Ocular Therapeutix, Inc. (FRA:0OT)
Germany · Delayed Price · Currency is EUR 10.41
+0.07 (0.68%)
At close: Nov 28, 2025
Ocular Therapeutix Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | -249.67 | -193.51 | -80.74 | -71.04 | -6.55 | -155.64 | Upgrade |
Depreciation & Amortization | 4.03 | 3.79 | 2.98 | 2.11 | 2.42 | 2.77 | Upgrade |
Loss (Gain) From Sale of Assets | -0.03 | - | 0 | 0 | -0 | - | Upgrade |
Stock-Based Compensation | 39.02 | 33.11 | 17.83 | 16.96 | 14.98 | 7.53 | Upgrade |
Other Operating Activities | 5.92 | 32.16 | -2.9 | -8.99 | -73.49 | 90.6 | Upgrade |
Change in Accounts Receivable | -0.53 | -6.21 | -4.85 | -0.19 | -8.88 | -9.7 | Upgrade |
Change in Inventory | -1.08 | -0.74 | -0.33 | -0.72 | -0.05 | -0.25 | Upgrade |
Change in Accounts Payable | 0.58 | -0.32 | 0.58 | -0.62 | 1.8 | -0.45 | Upgrade |
Change in Unearned Revenue | -0.19 | -0.26 | 0.43 | 0.96 | 1 | 12 | Upgrade |
Change in Other Net Operating Assets | 11.9 | -2.71 | -3.24 | 1.92 | 3.24 | -0.42 | Upgrade |
Operating Cash Flow | -190.06 | -134.68 | -70.23 | -59.6 | -65.55 | -53.55 | Upgrade |
Capital Expenditures | -9.37 | -1.29 | -6.09 | -3.72 | -1.19 | -0.84 | Upgrade |
Sale of Property, Plant & Equipment | 0.13 | - | - | - | - | - | Upgrade |
Investing Cash Flow | -9.24 | -1.29 | -6.09 | -3.72 | -1.19 | -0.84 | Upgrade |
Short-Term Debt Issued | - | - | 2 | - | - | 3.2 | Upgrade |
Long-Term Debt Issued | - | - | 82.47 | - | 3.72 | - | Upgrade |
Total Debt Issued | - | - | 84.47 | - | 3.72 | 3.2 | Upgrade |
Short-Term Debt Repaid | - | - | -2 | - | - | -3.2 | Upgrade |
Long-Term Debt Repaid | - | - | -26.13 | - | -4.17 | - | Upgrade |
Total Debt Repaid | - | - | -28.13 | - | -4.17 | -3.2 | Upgrade |
Net Debt Issued (Repaid) | - | - | 56.35 | - | -0.45 | - | Upgrade |
Issuance of Common Stock | 116.86 | 332.11 | 118.66 | 1.45 | 3.57 | 228.01 | Upgrade |
Other Financing Activities | - | - | -5.18 | - | -0.28 | - | Upgrade |
Financing Cash Flow | 116.86 | 332.11 | 169.83 | 1.45 | 2.85 | 228.01 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0 | Upgrade |
Net Cash Flow | -82.45 | 196.15 | 93.51 | -61.86 | -63.89 | 173.62 | Upgrade |
Free Cash Flow | -199.44 | -135.97 | -76.32 | -63.32 | -66.74 | -54.4 | Upgrade |
Free Cash Flow Margin | -357.52% | -213.37% | -130.59% | -122.96% | -153.36% | -312.56% | Upgrade |
Free Cash Flow Per Share | -1.15 | -0.86 | -0.89 | -0.77 | -0.81 | -0.90 | Upgrade |
Cash Interest Paid | 10.12 | 21.53 | 5.46 | 2.15 | 1.93 | 2.35 | Upgrade |
Levered Free Cash Flow | -123.38 | -87.59 | -49.44 | -33.3 | -38.07 | -40.3 | Upgrade |
Unlevered Free Cash Flow | -115.81 | -79.1 | -42.35 | -28.91 | -33.9 | -36.07 | Upgrade |
Change in Working Capital | 10.67 | -10.23 | -7.41 | 1.35 | -2.9 | 1.18 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.